Is ELN a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

1,367 people get ELN articles and Market Currents by email alert.

Get email alerts on ELN »

HEADLINES:

The Billion Dollar COPD Deal: Who Gains The Most?
Emerging Equities • Fri, May 17 • 1 Comment
Elan Announces Publication of Response Document

Business Wire (Wed, 5:14PM)
Complete Seth Klarman And Baupost Group Portfolio Update
Profit Fan • Wed, May 15 • 2 Comments
Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update
John Vincent • Wed, May 15 • 3 Comments
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Mon, May 13 • 28 Comments
Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

Business Wire (Mon, 2:03AM)
Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

Business Wire (Mon, 2:02AM)
Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors’ Retirement

Business Wire (Apr 25, 2013)
Elan Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Apr 24
Elan Reports First Quarter 2013 Financial Results

Business Wire (Apr 24, 2013)
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Mon, Apr 22 • 138 Comments
Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Unsolicited Tender Offer

Business Wire (Apr 22, 2013)
Elan Announces Final Results of its Tender Offer

Business Wire (Apr 18, 2013)
Cramer's Mad Money - The Fight Over Sprint Is Just Beginning (4/15/13)
SA Editor Miriam Metzinger • Tue, Apr 16
Elan’s Response to Royalty Pharma Announcement

Business Wire (Apr 15, 2013)
Acorda: A Biotech Company To Consider
Northrop Puckett • Sat, Apr 13 • 1 Comment
Elan EGM Resolution Passed with over 99% Approval

Business Wire (Apr 12, 2013)
Elan Announces Webcast of First Quarter 2013 Financial Results

Business Wire (Apr 10, 2013)
Elan Welcomes Irish Takeover Panel Statement

Business Wire (Apr 3, 2013)
Elan Announces Redemption of Its Senior Notes Due 2019

Business Wire (Apr 2, 2013)

Post-Tysabri, Will Elan Waste The Windfall?
Stephen Simpson • Fri, Feb 8 • 5 Comments

Post-Tysabri, Will Elan Waste The Windfall?
Stephen Simpson • Fri, Feb 8 • 5 Comments
Biogen Idec Pays Elan $3.25 Billion For Tysabri: Do We Leave, Or Stay?
Prohost Biotech • Wed, Feb 6 • 2 Comments
Elan's Split Will Create 2 Very Different Companies
Stephen Simpson • Tue, Aug 14, 2012 • 9 Comments
Elan: Between Speculation And Reality, Where Is The Firm Headed Now?
Prohost Biotech • Thu, Jan 19, 2012 • 3 Comments
Pharma: Don't Count Elan Out
Prohost Biotech • Mon, Jun 27, 2011 • 10 Comments
Elan Call Buyers Look for Springtime Rally
optionMONSTER • Wed, Apr 6, 2011
Bulls Pile Into Elan Ahead of Earnings
optionMONSTER • Mon, Feb 7, 2011 • 1 Comment
Elan Agrees to Pay $203.5M in Off-Label Marketing Case
Pharmalot • Thu, Dec 16, 2010
Elan, Dissident Directors Reach Detente
Pharmalot • Fri, Sep 17, 2010
Attacked From Within and Without, Elan CEO Condemns 'Falsehoods and Insinuations'
Pharmalot • Sun, Sep 12, 2010
Elan Holds Tight on Selling Drug Tech Unit
The Burrill Report • Fri, Aug 13, 2010 • 1 Comment
Elan Renews Spin-Off Hopes
The Burrill Report • Sun, Apr 25, 2010
Elan Corporation: Shares Seem Undervalued
Michael Catalin Vlaicu • Fri, Jul 10, 2009 • 5 Comments
A Bull's on the Loose at Elan
Mike Huckman • Thu, Jan 8, 2009
Who Is the Worst Biotech CEO?
Derek Lowe • Sun, Dec 14, 2008 • 3 Comments
Time to Buy Elan?
Bapcha's Stocks • Mon, Aug 4, 2008 • 12 Comments
Elan Corp. Now Dirt Cheap
Notable Calls • Fri, Aug 1, 2008
Elan: Actionable Buy Call
Notable Calls • Wed, Jul 30, 2008 • 9 Comments
Elan Corp.: Bounce on Goldman Positivity?
Notable Calls • Wed, Jul 30, 2008 • 3 Comments
Elan: New Multiple Sclerosis Drug Sales Will Be Key
Michael Shulman • Mon, Dec 3, 2007

The Billion Dollar COPD Deal: Who Gains The Most?
Emerging Equities • Fri, May 17 • 1 Comment
Complete Seth Klarman And Baupost Group Portfolio Update
Profit Fan • Wed, May 15 • 2 Comments
Tracking Seth Klarman's Baupost Group Holdings - Q1 2013 Update
John Vincent • Wed, May 15 • 3 Comments
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Mon, May 13 • 28 Comments
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Mon, Apr 22 • 138 Comments
Cramer's Mad Money - The Fight Over Sprint Is Just Beginning (4/15/13)
SA Editor Miriam Metzinger • Tue, Apr 16
Acorda: A Biotech Company To Consider
Northrop Puckett • Sat, Apr 13 • 1 Comment
Several Catalysts Behind My Decision To Establish A Position In Biogen Idec
Heather Ingrassia • Tue, Mar 5
VIX - Options Volatility And Market Sonar: Wednesday Recap
Erick McKitterick • Thu, Feb 28 • 36 Comments
4 Drug Delivery Companies That Deliver For Investors
Ryan's View • Wed, Feb 27
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Mon, Feb 25 • 72 Comments
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Thu, Feb 7
Cramer's Mad Money - No Pain In Hain (2/6/13)
SA Editor Miriam Metzinger • Thu, Feb 7 • 1 Comment
Wall Street Breakfast: Must-Know News
Wall Street Breakfast • Wed, Feb 6 • 164 Comments
European Largest Market Caps Best For 2013 EPS And Revenue Growth
John Kozey • Thu, Jan 31 • 2 Comments
VIX - Options Volatility Sonar: Wednesday Recap
Erick McKitterick • Wed, Jan 2 • 13 Comments
Pharma Continues To Move Forward With Alzheimer's Therapies
Vineet Dutta • Wed, Dec 19, 2012
VIX - Options Volatility Sonar: Tuesday Recap
Erick McKitterick • Tue, Dec 11, 2012
Today's Market News To Trade On: 5 Stocks Moving On News
Matthew Smith • Mon, Dec 10, 2012 • 3 Comments
How Steve Cohen Moves Stock
Felix Salmon • Tue, Nov 27, 2012 • 1 Comment

Elan Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Apr 24
Elan Corporation's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Feb 6
Elan Corporation CEO Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Oct 24, 2012
Elan Management Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Jul 25, 2012
Elan Q4 2009 Earnings Call Transcript
Wed, Feb 10, 2010
Elan Q3 2007 Earnings Call Transcript
Thu, Oct 25, 2007 • 1 Comment
Elan Q2 2007 Earnings Call Transcript
Fri, Jul 27, 2007

Elan Announces Publication of Response Document

Business Wire (Wed, 5:14PM)
Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

Business Wire (Mon, 2:03AM)
Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

Business Wire (Mon, 2:02AM)
Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors’ Retirement

Business Wire (Apr 25, 2013)
Elan Reports First Quarter 2013 Financial Results

Business Wire (Apr 24, 2013)
Early Movers: CAT, HAL, HAS & More

at CNBC.com (Apr 22, 2013)
Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Unsolicited Tender Offer

Business Wire (Apr 22, 2013)
Elan Announces Final Results of its Tender Offer

Business Wire (Apr 18, 2013)
Last Call: Boston Bombing Aftermath

at CNBC.com (Apr 16, 2013)
Last Call: Boston Bombings Aftermath

at CNBC.com (Apr 16, 2013)
Elan’s Response to Royalty Pharma Announcement

Business Wire (Apr 15, 2013)
Europe Shares Close Down After Commodities Sell-Off

at CNBC.com (Apr 15, 2013)
Early Movers: S, DISH, C, PCS & More

at CNBC.com (Apr 15, 2013)
Early Movers: JPM, GPS, HD & More

at CNBC.com (Apr 12, 2013)
Elan EGM Resolution Passed with over 99% Approval

Business Wire (Apr 12, 2013)
Elan Announces Webcast of First Quarter 2013 Financial Results

Business Wire (Apr 10, 2013)
Elan Welcomes Irish Takeover Panel Statement

Business Wire (Apr 3, 2013)
Elan Announces Redemption of Its Senior Notes Due 2019

Business Wire (Apr 2, 2013)
Elan Announces Closing of TYSABRI® Collaboration Transaction with Biogen Idec

Business Wire (Apr 2, 2013)
ADDING MULTIMEDIA New TYSABRI Data Reaffirm Substantial Efficacy in Treatment of People with MS and Demonstrate Stability of Anti-JCV Antibody Status

Business Wire (Mar 18, 2013)

ELN vs. ETF Alternatives

Company Description

Elan Corporation, plc, an Irish public limited company, is a neuroscience-based biotechnology company, listed on the Irish and New York Stock Exchanges, and headquartered in Dublin, Ireland. We were incorporated as a private limited company in Ireland in December 1969 and became a public limited... More

Sector: Healthcare

Industry: Drug Delivery & Accessories

Country: Ireland

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 15, 11:50 AM Seth Klarman added two new positions to Baupost in Q1, with Elan (ELN) now 3.5% of his portfolio and DirecTV (DTV) 0.38%. He added to already major positions in BP, AIG, ROVI, and IDIX, and completely sold out of GNW, and ANV. 1 Comment
Monday, May 13, 5:49 AM Elan (ELN) will make a one time cash payment of $1B to Theravance (THRX) for a 21% participation interest in future royalty payments from THRX's four respiratory collaborations with GlaxoSmithKline (GSK) including the recently-approved Breo Ellipta/Relvar treatment for COPD. The news comes on the heels of THRX's earnings report and concurrent announcement that it will split into two separate publicly traded companies. (PR) Comment! [Healthcare]
Thursday, May 2, 7:25 AM Royalty Pharma officially submits its $11.25/share cash offer to Elan (ELN), again making the case that this month's Dutch Auction makes clear the price is a fair one. "J&J's actions (they tendered at $11.25) speak volumes." (PR) 1 Comment [Healthcare, Breaking News, M&A]
Wednesday, April 24, 5:35 AM Elan (ELN) Q1 EPS of -$0.05. Revenue including Tysabri of $344.0M (+19% Y/Y). (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, April 24, 12:05 AM Notable earnings before Wednesday’s open: ABB, ABX, ASH, ATI, AVY, BA, BYD, CFR, CKSW, COR, CP, CS, CVE, DPS, EDU, ELN, EMN, ERIC, F, FDML, GD, GLW, GRA, HCBK, HES, ICON, LAD, LL, LLY, LO, MDCO, MSI, MTH, NDAQ, NOC, NS, NVS, NYCB, OC, OCR, OSIS, PG, PLD, PX, RES, ROK, S, SO, SVU, TEL, TKR, TMO, TROW, TUP, USG, VLY, VMED, WAB, WHR, WLP, WM, WYN Comment! [Earnings]
Tuesday, April 23, 5:30 PM Notable earnings before Wednesday’s open: ABB, ABX, ASH, ATI, AVY, BA, BYD, CFR, CKSW, COR, CP, CS, CVE, DPS, EDU, ELN, EMN, ERIC, F, FDML, GD, GLW, GRA, HCBK, HES, ICON, LAD, LL, LLY, LO, MDCO, MSI, MTH, NDAQ, NOC, NS, NVS, NYCB, OC, OCR, OSIS, PG, PLD, PX, RES, ROK, S, SO, SVU, TEL, TKR, TMO, TROW, TUP, USG, VLY, VMED, WAB, WHR, WLP, WM, WYN Comment! [Earnings]
Monday, April 22, 6:46 AM Elan (ELN) has rebuffed Royalty Pharma's reduced $11.25-a-share takeover offer, saying the bid "grossly undervalues" the Irish pharmaceuticals company. Royalty cut its bid last week from $12 following a $1B stock buyback by Elan, the results of which suggest that the company's investors support the view that Royalty's bid is too low - 73% of shares excluding those of Johnson & Johnson were not tendered in the pre-announced price range of $11.25-$13.00. (PR) 1 Comment [Healthcare, M&A]
Thursday, April 18, 9:40 AM Johnson & Johnson (JNJ) tenders 107.4M Elan (ELN) shares at the strike price of $11.25 in the latter's $1B stock buyback. The total number of shares tendered is 239.7M, of which Elan plans to purchase 76%. Elan is retiring 14.8% of the stock in issue as part of the repurchase plan. (PR) Comment! [Healthcare]
Monday, April 15, 7:29 AM U.S. investment firm Royalty Pharma offers to acquire Elan (ELN) for $11-12/share, depending on the outcome of its dutch auction. Royalty says its analysis of Elan's Tysabri royalty and the implied valuation of Elan's economics in Tysabri leads its to believe its offer "represents a full and fair value for Elan." Ireland's Takeover Panel had given Royalty until May 10 to announce a takeover offer or end its $6.5B pursuit of the drugmaker. Elan has rejected previous overtures. (PR) Comment! [Breaking News, Healthcare, M&A]
Friday, April 12, 4:48 PM SAC Capital is reportedly being sued by Wyeth investors over insider trading, just one month after it settled with federal regulators for over $600M under similar allegations. SAC came under fire last year as former fund manager Mathew Martoma was charged with illegally obtaining results from an Alzheimer's drug trial being conducted by Wyeth (now part of Pfizer (PFE)) and Elan (ELN), then trading on the information before the data was made public. Comment! [Financials, Healthcare]
Friday, April 12, 10:59 AM Elan's (ELN -1.3%) shareholders have overwhelmingly approved a plan to buy back $1B in stock following the sale of Tsabri to Biogen Idec (BIIB +2.4%), as speculation mounts that an earlier takeover indication by Royalty Pharma might be sweetened. Royalty approached ELN in February with an $11 per share potential offer, valuing the company at $6.55B, which was rejected by ELN. Last week, Ireland's Takeover Panel told the pharmaceutical investor to either step up and announce an official takeover offer for the company by May 10, or walk away. Comment! [Healthcare, Global & FX, M&A]
Wednesday, April 3, 8:01 AM Ireland's Takeover Panel tells U.S. investment firm Royalty Pharma to either announce a takeover offer for Elan (ELN +0.1%) by May 10 or end its $6.5B pursuit of the drugmaker. Elan, which has rejected Royalty's indicative approach of $11/share, welcomed the panel's deadline. (PR) Comment! [Healthcare, M&A]
Tuesday, April 2, 6:08 PM Biogen Idec (BIIB) completes its purchase of Elan's (ELN) interest in Tysabri, gaining full strategic, commercial and decision-making rights to the relapsing MS drug treatment. [BIIB plans to give further details and updated financial guidance during it's upcoming Q1 earnings announcement. Shares +0.3% AH. Comment! [Healthcare, M&A]
Monday, March 18, 8:10 AM Biogen's (BIIB) and Elan's (ELN) Tysabri treatment has demonstrated its "efficacy compared to other multiple sclerosis (MS) treatments" in several studies. The research also provided more data that shows the stability of anti-JC virus (JCV) antibodies, and improved outcomes for the brain infection PML if it's detected early. (PR) 1 Comment [Healthcare]
Monday, March 11, 9:29 AM Elan (ELN) +4.2% premarket after announcing Friday it will pay as much as $13/share, or a premium of 13% from Friday’s closing price, to buy back stock in a plan intended to reward stockholders who remain invested in the company following the sale of its Tysabri multiple sclerosis drug. 1 Comment [Healthcare, On the Move]
Friday, March 8, 5:37 PM After-hours top gainers, as of 5:15 p.m.: ELN +7%. THOR +3%. GAME +3%. TTI +2%. VELT +2%.
After-hours top losers: RMBS -4%. LKQ -4%. EZPW -4%. MBLX -3%. CYS -3%. Comment! [On the Move]

Asif Suria
Royalty Pharma Offers to Buy Elan for $6.6 Billion $ELN http://nyti.ms/YrSrQk
Feb 25, 9:01 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

x oil -field
DealB%k: $ELN New Details in SAC Case. http://nyti.ms/XRGBMN
Feb 4, 3:35 AM
Reply (1)

• !Report Abuse
View all 1 replies
x oil -field: SAC Capital Advisors LP told employees-business partners a $1B withdrawal is expected,amid insider-trading probe.http://bloom.bg/WPChNy
Feb 4, 3:35 AM
• !Report Abuse
Add a reply...

140 characters

mitrado
Investing in growing companies, $AMRN & $SPPI, with good or at least, very promising products failed. Should I buy $ELN & $MNTA instead? :-P
12/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Profitable Healthcare Stocks Forecasted To Grow EPS By At Least 25% http://bit.ly/UhMyaw $ALXN $ELN $FRX $VRTX @ZetaKap
10/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
6 Mid Cap Stocks With Steady Profits And Projected EPS Growth Above 25% http://bit.ly/OQV8Wk $FRX $ANV $ACC $ELN $COG $SD @ZetaKap
8/11/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Travis Chapman
Wow, PFE ELN JNJ bapi data out TODAY, and it looks like even ApoE4 non-carriers didn't benefit
8/6/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
4 Healthcare Stocks Fueling Growth On Strong Profitability http://bit.ly/N8eV5c $PGNX $FRX $POZN $ELN @ZetaKap
7/3/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Kudrna
Updated FDA Calendar $SPY $IWM $QQQ $CBRX $BIIB $ELN $BMY $BMY $LLY $ALKS http://bit.ly/zyfS5U
1/5/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

0ZJ
Not a bad day. Consistently beating the indexes at least. Long: AAPL, CELG, DD, ELN, OKS
12/30/11
Reply (4)

• !Report Abuse
View all 4 replies
0ZJ: ...I'm thinking I was at least a day earlier. Per my indicators I could short again today. Comtemplating it.
12/30/11
• !Report Abuse
ker.nulov@gmail.com: I mean, when current month's (high - low) value is inside previous month's (high-low) which usually means that no trend change happened.
12/30/11
• !Report Abuse
Add a reply...

140 characters

Asif Suria
Elan $ELN looks to add to recent gains on rumors of a possible takeover bid from Johnson & Johnson $JNJ http://bit.ly/uN5FXG
12/30/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

x oil -field
DealB%k: $ELN New Details in SAC Case. http://nyti.ms/XRGBMN
Feb 4, 3:35 AM
Reply (1)

• !Report Abuse
View all 1 replies
x oil -field: SAC Capital Advisors LP told employees-business partners a $1B withdrawal is expected,amid insider-trading probe.http://bloom.bg/WPChNy
Feb 4, 3:35 AM
• !Report Abuse
Add a reply...

140 characters

0ZJ
Not a bad day. Consistently beating the indexes at least. Long: AAPL, CELG, DD, ELN, OKS
12/30/11
Reply (4)

• !Report Abuse
View all 4 replies
0ZJ: ...I'm thinking I was at least a day earlier. Per my indicators I could short again today. Comtemplating it.
12/30/11
• !Report Abuse
ker.nulov@gmail.com: I mean, when current month's (high - low) value is inside previous month's (high-low) which usually means that no trend change happened.
12/30/11
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Elan (ELN) is up 111% for the year. I think it could still head higher. http://yhoo.it/nx4E2L=
12/20/11
Reply (1)

• !Report Abuse
View all 1 replies
John Gowen: Good news for this household.
12/20/11
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Bloomberg said Ireland wants to leave the EU. Maybe this is a good time to buy Elan (ELN). http://yhoo.it/nx4E2L=
10/7/11
Reply (1)

• !Report Abuse
View all 1 replies
Irishmedic: Michael, just got of the phone with my ma, not exiting the EU, they will be the first PIIGS to pay of the loan, well so the Taoiseach say!
10/7/11
• !Report Abuse
Add a reply...

140 characters

Joshua Hayes
new instablog: Rally Attempt Begins with Two Days of Gains. Medical stocks are our leaders. VRUS ELN JAZZ STAA ALXN BIIB RGEN MAKO OSUR BMY
10/5/11
Reply (1)

• !Report Abuse
View all 1 replies
cowpieTX: i manage a diagnostic imaging center for a 17b market cap company. the cuts are real and they are deep. tread carefully.
10/5/11
• !Report Abuse
Add a reply...

140 characters

ELN Elan Corporation, plc

ELN

Elan Corporation, plc